Prevenar 13 has already been denied a patent by the European Patent Office and Médicins sans Frontières (MSF; Doctors Without Borders) is hoping to make it two strikes in a row against Pfizer Inc.’s best-selling vaccine.
Hearings are being held at the Indian Patent Office in capital New Delhi on Pfizer’s patent application and a ruling...





